No single score captures the burden of treatment in people with cystic fibrosis (pwCF), according to systematic review study findings published in the Journal of Cystic Fibrosis.

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

I spent my childhood and young adulthood being told I was “too young and healthy” to be dealing with the health issues I experienced. But as an adult, I was determined to find answers, and eventually, ...

A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

As noted above, stellate cell activation is the central event in hepatic fibrosis. Activation consists ... undergo "activation" which connotes a transition from quiescent vitamin A-rich cells ...